CDx
List of approved Companion Diagnostics (CDx) in Japan (by Intended Use)
- CDx approved for identifying eligible patients
- Updated as of April 6, 2026[298KB] (The updated parts are indicated in yellow)
- CDx approved for treatment optimization
- Updated as of May 14, 2025[106KB] (The updated parts are indicated in yellow)
Drug-Agnostic CDx
List of therapeutic products for which eligible patients can be identified by Drug-Agnostic CDx
- Updated as of April 28, 2026[135KB] (The updated parts are indicated in yellow)
- Evaluation of the applicability of Drug-Agnostic CDx related to “CDx for EGFR gene mutation (excluding exon 20 insertion mutation) in patients with non-small cell lung cancer”
Evaluation Report on Applicability to Drug-agnostic Companion Diagnostics [312KB]